Delivery Order SPE2DB22D2005-SPE2DB24FJRU0
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REXULTI 1 mg tablets. The $19,503.45 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, is for the supply of REXULTI 1 MG TABLET 30S prescription medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,326.58 firm fixed price delivery order does not have a set-aside designation. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award is a Delivery Order worth $23,106.99 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of REXULTI 1 MG TABLET 30S. The contract has a period of performance through June 18, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,998.80 firm-fixed-price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,351.59 to provide REXULTI 2 MG TABLET 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 20, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of REXULTI 2 MG TABLET 30S to the Defense Logistics Agency (DLA). The $8,479.18 firm fixed-price delivery order has a completion date of May 19, 2025 and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $10,497.08 firm-fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DB26FJEA6. The contract provides for the delivery of REXULTI 2 MG TABLET 30S, a specialty pharmaceutical product, with a completion date of October 25, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product REXULTI 2 MG TABLET 30S. The contract, which has a Firm Fixed Price pricing type, is a Delivery Order valued at $2,654.22 with a completion date of June 3, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,654.22 firm fixed price delivery order is for the supply of REXULTI 2 MG TABLET 30S, with a period of performance through June 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under contract number SPE2DB22D3016|SPE2DB25FARY9. The $13,421.84 fixed-price delivery order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...